Mineralocorticoid receptor antagonists and prevention of atrial fibrillation in patients with hypertension
Kardiol Pol
.
2020 Jun 25;78(6):609-610.
doi: 10.33963/KP.15452.
Epub 2020 Jun 25.
Author
Rafał Dąbrowski
1
Affiliation
1
Department of Coronary Artery Disease and Cardiological Rehabilitation, The Cardinal Stefan Wyszyński National Institute of Cardiology, Warsaw, Poland. rdabrowski45@gmail.com
PMID:
32589380
DOI:
10.33963/KP.15452
No abstract available
Publication types
Letter
Comment
MeSH terms
Atrial Fibrillation*
Humans
Hypertension*
Mineralocorticoid Receptor Antagonists
Risk Factors
Secondary Prevention
Substances
Mineralocorticoid Receptor Antagonists